Gestational Thrombocytopenia: Approach and Management

Definition

• Goldman-Cecil Medicine, p. 1815; Washington Manual of Medical Therapeutics, p. 764

Epidemiology

• Thrombocytopenia occurs in 7-10% of all pregnancies
• GT accounts for ~75% of all pregnancy-related thrombocytopenia
• Occurs in 5-7% of otherwise uncomplicated pregnancies
• Hypertensive disorders (preeclampsia/HELLP): 15-20%
• Immune causes (ITP): 3-4%
• Rare (constitutional, infections, malignancy): 1-2%
• Goldman-Cecil Medicine, p. 1815; Washington Manual, p. 764

Pathophysiology

Distinguishing Features of GT vs. Other Causes

• Goldman-Cecil Medicine, p. 1815; Textbook of Family Medicine, p. 1175

• Harrison's Principles, 22e; Textbook of Family Medicine

Differential Diagnosis of Thrombocytopenia in Pregnancy

1. Gestational thrombocytopenia (most common, 75%)
2. Preeclampsia / Eclampsia / HELLP syndrome
3. ITP (immune thrombocytopenic purpura)
4. TTP (thrombotic thrombocytopenic purpura)
5. HUS (hemolytic uremic syndrome)
6. DIC (disseminated intravascular coagulation)
7. Acute fatty liver of pregnancy (AFLP)
8. SLE / antiphospholipid antibody syndrome
9. Drug-induced thrombocytopenia
10. Viral infections (HIV, hepatitis C, CMV)
11. Nutritional deficiency (B12, folate)
12. Pseudothrombocytopenia

Diagnostic Workup

1. History: Prior thrombocytopenia (pre-pregnancy or between pregnancies), bleeding symptoms, medications, viral exposure
2. Blood pressure / urinalysis: Rule out preeclampsia
3. CBC with peripheral smear: Look for schistocytes (TTP/HELLP), platelet morphology
4. LFTs + LDH + haptoglobin + bilirubin: Rule out HELLP, AFLP, TTP
5. Coagulation studies (PT, aPTT, fibrinogen): Rule out DIC
6. ADAMTS13 level: If TTP suspected (very low <10% supports TTP)
7. Antiphospholipid antibodies / ANA: If lupus or antiphospholipid syndrome suspected
8. Platelet-associated antibodies: Not helpful - found equally in GT and ITP
9. Bone marrow biopsy: Rarely needed; only if diagnosis unclear

• Washington Manual, p. 764; Goldman-Cecil Medicine, p. 1815

Management of Gestational Thrombocytopenia (True GT)

• No pharmacologic intervention needed
• No modification of delivery route required
• No fetal blood sampling needed
• Platelet count normalizes spontaneously after delivery (within days to weeks)
• A neonatologist should evaluate the newborn as routine care
• Monitor platelet count postpartum to confirm resolution
• Goldman-Cecil Medicine, p. 1815; Textbook of Family Medicine, p. 1175

Management of ITP in Pregnancy (when GT is ruled out)

Treatment Thresholds

First-Line Treatment

1. Corticosteroids (prednisolone 1 mg/kg/day) - first line, but monitor for:
   • Gestational diabetes, hypertension, premature labor, placental abruption
2. IVIG (1 g/kg IV) - first line, especially for urgent situations or steroid failure
   • Rapid onset; useful near delivery or for acute bleeding
3. Combination corticosteroids + IVIG if either agent alone fails

Second-Line / Refractory Treatment

1. Laparoscopic splenectomy - best performed in 2nd trimester if needed; technically difficult in 3rd trimester
2. Rituximab - not teratogenic but causes prolonged lymphopenia in mother and neonate; use with caution
3. TPO receptor agonists (romiplostim, eltrombopag) - safety in pregnancy not established; limited case reports only
4. Platelet transfusion - reserved for severe hemorrhage; not for routine thrombocytopenia

• Goldman-Cecil Medicine, p. 1815-1816; Creasy & Resnik MFM, p. 1293; Textbook of Family Medicine, p. 1175

Fetal/Neonatal Considerations

• GT: No fetal thrombocytopenia - no additional fetal monitoring required
• ITP: Maternal IgG anti-platelet antibodies cross the placenta; fetal thrombocytopenia possible
  • However, maternal platelet count does not correlate with fetal/neonatal platelet count
  • Fetal blood sampling to check platelet count carries significant risk and is NOT recommended
  • Neonatal thrombocytopenia (platelet <100,000/μL) occurs in only ~15% of ITP pregnancies
  • Risk of neonatal intracranial hemorrhage is 1-2%
  • Best predictor of neonatal thrombocytopenia = prior sibling with neonatal thrombocytopenia
  • Monitor neonate's platelet count for ~1 week after delivery
  • ITP per se is NOT an indication for cesarean section
• Creasy & Resnik MFM, p. 1293; Textbook of Family Medicine, p. 1175

Management of Preeclampsia / HELLP-Associated Thrombocytopenia

• Immediate delivery is the definitive treatment (syndrome is placenta-driven)
• If no improvement by 3rd postpartum day, consider TTP, ITP, or DIC
• If TTP-like picture persists: plasma exchange
• Goldman-Cecil Medicine, p. 1815

Management of TTP in Pregnancy

• Plasma exchange initiated urgently if TTP strongly suspected
• ADAMTS13 <10% supports TTP diagnosis
• Can coexist or mimic preeclampsia - TTP more likely if onset is in early pregnancy (before preeclampsia is typical)

Summary Algorithm

Thrombocytopenia found in pregnancy
         ↓
Check: BP, proteinuria, LFTs, CBC smear, coagulation screen
         ↓
Platelet >70-100 × 10⁹/L + 3rd trimester + no symptoms
+ no prior thrombocytopenia (except prior pregnancies)
+ no hypertension / hemolysis / elevated LFTs
         ↓
→ GESTATIONAL THROMBOCYTOPENIA
→ No treatment. Routine obstetric care. Confirm resolution postpartum.

Platelet <70 × 10⁹/L OR first trimester OR prior history
         ↓
→ Evaluate for ITP, preeclampsia, HELLP, TTP, DIC
→ Manage cause-specifically (see above)

Recent Evidence (2024-2026)

• GT is the most common cause (75%) of thrombocytopenia in pregnancy - benign, no treatment needed
• Platelet <100,000/μL makes GT unlikely; <70,000/μL makes it very unlikely
• ITP requires treatment at platelet <30,000/μL in 2nd/3rd trimester; corticosteroids and IVIG are first-line
• Delivery mode is not determined by ITP status alone; platelet >80,000/μL needed for neuraxial anesthesia
• HELLP/preeclampsia - delivery is definitive; TTP - plasma exchange is treatment of choice